首页|新生儿持续性肺动脉高压病理生理机制及治疗的研究进展

新生儿持续性肺动脉高压病理生理机制及治疗的研究进展

扫码查看
新生儿持续性肺动脉高压是导致新生儿死亡的重要原因之一,是一类恶性进行性肺血管疾病,病情持续进展引发患儿呼吸受限、低氧血症,最终导致右心衰竭严重威胁患儿的生命。而存活的患儿也常留有其他系统的后遗症,长期影响其生活质量。现就新生儿持续性肺动脉高压的病理生理机制及治疗进展展开综述,以期为相关研究及临床诊断和治疗提供参考。
Pathophysiological Mechanism and Treatment of Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn is one of the important causes of death in newborn infants,and it is a type of malignant progressive pulmonary vascular disease.The condition leads to respiratory restriction,hypoxemia,and eventually right heart failure,which seriously threatens the lives of children.Surviving children often have sequelae of other systems,which have a long-term impact on their quality of life.This article reviews the pathophysiological mechanism and treatment progress of neonatal persistent pulmonary hypertension,in order to provide reference for related research,clinical diagnosis and treatment.

Persistent pulmonary hypertension of the newbornPathophysiological mechanismDrug treatmentInhaled nitric oxide

禚月、鲍霞、庄贺、石金虎

展开 >

山东中医药大学康复医学院,山东 济南 250355

山东大学第二医院心血管内科,山东 济南 250033

新生儿持续性肺动脉高压 病理生理机制 药物治疗 吸入性一氧化氮

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(12)